NCT03967977 2026-01-26Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial CarcinomaBeOne MedicinesPhase 3 Recruiting420 enrolled
NCT05661955 2025-11-21A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.BeOne MedicinesPhase 1/2 Active not recruiting113 enrolled